AIDS Prevention Initiative Nigeria Monitoring and Evaluation in the Transition Toyin Jolayemi – APIN Ltd Seema Meloni - Harvard.

Slides:

Advertisements

Similar presentations

Anne Sholander, MT(ASCP), International QA/QC Coordinator, SMILE

Advertisements

CDC Mozambique Transition Monitoring Approach 8 th Annual Track 1 meeting, August 12, 2010 Charity Alfredo CDC-Mozambique.

1 KwaZulu Natal Province URC Annual Meeting December 2010 Provincial Coordinators: Mrs. P Harrison Mrs. M Ngema Mrs. V Mbatha.

Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,

VHA/ DoD Clinical Practice Guideline Medically Unexplained Symptoms (MUS): Chronic Pain & Fatigue “Tool Kit” Timothy S. Corcoran, Lt Col, USAF, MC Office.

Designing a National PMTCT Impact Evaluation for Option B+ in Malawi Dr. Beth A. Tippett Barr, CDC-Malawi AIDS Turning the Tide Together.

Division of Women’s Health Quality Assurance / Quality Improvement Process February 21, 2013.

Integrated Monitoring and Evaluation of HIV Programs in Malawi Dr Andreas Jahn 1,2 1 Dept. for HIV and AIDS, MOH, Malawi 2 I-TECH Malawi.

Providing Treatment, Restoring Hope Program Evaluation and Improvement Using Small Tests Of Change Kristen A. Stafford, MPH Pat Bass, RN, MA Track 1.0.

Utilizing Facility Data for Program Monitoring Valerie Koscelnik Track 1 ART Program Meeting Maputo, August 12, 2010.

ClASS MODULES: BREAKOUT SESSIONS. ClASS CLINICAL MODULE.

Sean Berenholtz, MD MHS FCCM September 20, 2011 at 2ET/1 CT/12 MT/11 PT Ventilator Associated Pneumonia Prevention CLABSI Supplemental Call Series.

The Implementation of the WHO Asia Pacific Treatment Metrics Dr. YU, Dongbao WHO Regional Office for the Western Pacific 20 July, 2014 Antiretroviral Treatment.

Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.

experience from Lesotho

HIV Care and Treatment: Benefits of Electronic Medical Records Phyllis Kanki 1, Seema Meloni 1,Beth Chaplin 1, Bolanle Banigbe 2, Prosper Okonkwo 2 1 Harvard.

Surveillance to measure impact of ART Theresa Diaz, MD MPH CDC Global AIDS Program.

Performance Monitoring and Financial Reports Performance Monitoring and Financial Reports UNAIDS and Unified Budget and Workplan (UBW)

Assessing & Improving Quality of Care Newly Developed Quality of Care Tools President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting Seema.

Overview Burkina--- ART Population: 11 millions Prevalence: 6.6% (surveillance data) Estimate of 650,000 PLWHA 300 peoples with red cross 2000 people to.

1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.

The Effect of Quality Improvement on Racial Disparities in Diabetes Care Thomas D. Sequist, MD MPH Alyce S. Adams, PhD Fang Zhang, MS Dennis Ross-Degnan,

Quality Assessment and Improvement Harvard – PEPFAR Tanzania, Nigeria and Botswana.

Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Sombat Thanprasertsuk MD, MPH Department of Disease Control, MOPH Thailand 2 July 2013.

Quality of Care at a Multi-site PEPFAR-funded ART Program: From Measuring to Improvement.

Elements and Applications of the NACS Approach Serigne Diene, Senior Nutrition and HIV Advisor (FANTA/FHI360) AIDS Turning the Tide Together.

Satellite Roll Out and Lab Capacity Building in Harvard PEPFAR Dr. Toyin Jolayemi APIN/Harvard PEPFAR, Nigeria.

HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.

Orientation on HIV care and ART Recording and Reporting System.

Evaluation of the AETC HIV Testing Initiative. Background In 2006, revised recommendations for routine HIV screening were released. AETCs have worked.

1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.

Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.

Scaling up HIV Paediatric care Harvard – PEPFAR Program Chalamilla Guerino

COMPUTER ALERT SYSTEM AND TELEPHONE SUPPORT TO IMPROVE ANTIRETROVIRAL THERAPY ADHERENCE Kasparas, Gustavo Guillermo (1); Iannella, María del Carmen (2);Bugarin,

Monitoring Transition of Harvard Support to Management and Development for Health (MDH), Tanzania Mary Mwanyika-Sando, MD 8 th Annual CDC/HRSA Track 1.0.

Data dissemination meeting February 28, 2007 ICAP New York.

Transitioning to the New CDC Guidelines CDC HIV Integration Check List Region VIII Thursday, June 14 th 2007 New Orleans, Louisiana JSI Research and Training.

Use of Routine Feedback Reports to Site and District Staff in Cote d’Ivoire Hermann Brou Annual Meeting, M&E satellite meeting Johannesburg, July 28, 2010.

Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.

Integration of TB and HIV Screening, Care and Treatment in Mulago Hospital, Uganda Rhoda Wanyenze, Doris Mwesigire, Henry Luzze, Violet Gwokyalya, Julius.

Sub module 1 Introduction to HIV care and ART recording and reporting system.

Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.

Mövenpick Royal Palm Hotel Dar es Salaam, Tanzania August 4-6, 2009 The 7th Annual Track 1.0 ART Program Meeting.

THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.

Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.

Facility supervision by the District Health Teams (DHTs) in Rwanda Track1 Meeting Maputo, Mozambique, August 10 th -12 th Dr. Ruben Sahabo.

Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.

TB and HIV integrated services at Martin Preuss Centre in Lilongwe, Malawi : “The Lighthouse Trust initiative” Dr Sam Phiri Executive Director Lighthouse.

Data…Data…Data December 8, 2010 On the CUSP: Stop CAUTI 1.

Jeroen Van’t Pad Bosch, Technical Director Elizabeth Glaser Pediatric AIDS Foundation, Tanzania EGPAF PROJECT HEART STRENGTHENING HEALTH SYSTEMS THROUGH.

ICAP Quarterly Master Slide Set July-September 2007.

HHS/CDC Track 1.0 Transition in Rwanda Dr Ida Kankindi, Rwanda Ministry of Health Dr Felix Kayigamba, CDC-Rwanda August

1 in+care Campaign Pre-Work Webinar October 12, 2011 Clemens Steinbock Director National Quality Center.

11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,

Harvard PEPFAR BotswanaNigeriaTanzaniaTotal Persons enrolled in HIV Care 18,687* 91,87571, ,487* Persons initiated on ART 13,275* 118,295 61,69644,404129,375*

From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.

Improving HIV care and support service performance in Côte d’Ivoire M. N’goran 1 ; S. Ramachadran 2 ; J. Essombo 1 et al M. N’goran 1 ; S. Ramachadran.

Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.

Differentiated Monitoring & Evaluation

Earlier treatment and lower mortality in infants Initiating ART at

UMRG 3rd Learning Session: July 19th, 2012

Creating an RFP in a collaborative environment

Integrating Cancer care into HIV care

Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,

Implementation of the Appointment Spacing Model of Differentiated Service Delivery in Ethiopia: Successes and Challenges Tamrat Assefa1, Zenebe Melaku1,

Find and Treat All Missing Persons with TB

HIV Quality Improvement (QI) and the Treatment Cascade: How QI has Impacted Reach, Recruitment, Testing, Treatment, and Retention Efforts in Thailand?

Dr. Velephi Okello, Principal Investigator, MaxART Trial

Routine Counselling and HIV testing (CT) for TB patients in Malawi: Rhehab Chimzizi TB-HIV Programme officer National TB Control Programme-Malawi.

Stakeholder engagement and research utilization: Insights from Namibia

Presentation transcript:

AIDS Prevention Initiative Nigeria Monitoring and Evaluation in the Transition Toyin Jolayemi – APIN Ltd Seema Meloni - Harvard

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria Background Harvard supporting sites since 2004 Since 2008, APIN has been funded by CDC Nigeria to transition sites from Harvard Year 1 SHL 2 Satellites 1 PHC Year 2 LUTH NIMR Year 3 UCH Adeoyo 3 Satellites

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria Service Delivery Based on National Guidelines and Harvard/APIN protocols

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria Overall Enrollment Jul-Dec 08Jan-Jun 09Jul-Dec 09Jan-Jul 10 NIMR New on Care 1,3441,4001,2711,169 New on ART Current on Care 6,7007,2617,7417,932 Current on ART 4,6844,9225,1575,510 LUTH New on Care1,0481, New on ART Current on Care5,1885,6615,9626,317 Current on ART3,9894,2374,6234,960

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria QA/QI (1): Continuity of Care Jul-Dec 08Jan-Jun 09Jul-Dec 09Jan-Jul 10 NIMR % of patients with ≥1 clinical visit in the last 6 months and 6 months apart % of ART patients who had ≥1 pharmacy pick-up and/or ≥1 clinical visit in the last 6 months LUTH % of patients with ≥1 clinical visit in the last 6 months and 6 months apart % of ART patients who had ≥1 pharmacy pick-up and/or ≥1 clinical visit in the last 6 months

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria QA/QI (2): OIs including TB Jul-Dec 08Jan-Jun 09Jul-Dec 09Jan-Jul 10 NIMR % of patients who were screened for TB by clinical symptoms during the past 6 months % of patients initiated on TB treatment within 2 months of confirmed TB diagnosis % of patients with at least one CD4 count ≤350 on CPT LUTH % of patients who were screened for TB by clinical symptoms during the past 6 months % of patients initiated on TB treatment within 2 months of confirmed TB diagnosis % of patients with at least one CD4 count ≤350 on CPT

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria QA/QI (3): Patient Monitoring Jul-Dec 08Jan-Jun 09Jul-Dec 09Jan-Jul 10 NIMR % of new patients who got baseline CD % of patients who got ≥1 CD4 assessment during 6- month review period LUTH % of new patients who got baseline CD % of patients who got ≥1 CD4 assessment during 6- month review period

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria Cohort Analysis Date Range for 6 Month CD4 CountJul-Dec 08Jan-Jun 09Jul-Dec 09Jan-Jul 10 Starting Cohort Date RangeAug 07 - Jan 08Feb 08 – Jul 08Aug 08 – Jan 09Feb 09 – Jul 09 NIMR # of patients in the starting cohort # with baseline CD4 count 481 (90%)980 (86%)685 (91%)727 (91%) Median baseline CD4 count # from the starting cohort still picking up ART at month (82%)948 (83%)602 (80%)672 (84%) # with CD4 count at month (83%)790 (83%)516 (86%)436 (65%) Median CD4 count at month LUTH # of patients in the starting cohort # with baseline CD4 count 511 (97%)518 (95%)563 (96%)658 (93%) Median baseline CD4 count # from the starting cohort still picking up ART at month (90%)389 (71%)402 (68%)544 (77%) # with CD4 count at month (64%)329 (85%)353 (88%)453 (83%) Median CD4 count at month

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria Clinical Outcomes Jul-Dec 08Jan-Jun 09Jul-Dec 09Jan-Jul 10 NIMR % with VL≤400 after 6 months on ART LUTH % with VL≤400 after 6 months on ART

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria Transition of QA Efforts APIN Central Central QA committee in place QA indicators harmonised with GON QA/QI toolkit in place Training on QA/QI framework and processes Mentoring of Sites Site Site QA committee in place including focal person and data staff QA framework/plans in place QA activities ongoing Sites starting to run data for QI Training on QA/QI framework and processes Technical Assistance from Harvard QA /QI SOP and QUiC tool developed; Analysis for QI Support training and provide TA on QA/QI

Saturday, September 19, 2015 AIDS Prevention Initiative Nigeria Saturday, September 19, AIDS Prevention Initiative Nigeria Summary Development of tools to monitor the impact of transition on clinical outcomes is critical. Methods of analysis and ultimate significance require empirical approach. Increased communication with transitioned site personnel and patients will inform the process.